News9Live on MSN
No demand for power-sharing in NDA: EPS shuts down coalition govt speculation in Tamil Nadu
Responding to Union Minister Amit Shah's recent remarks about a potential NDA coalition government, Palaniswami made it clear that the AIADMK-led front is united under a single leadership vision.
KalVista Pharmaceuticals, Inc. is rated a Strong Buy due to EKTERLY's global launch and robust initial sales momentum. Read ...
Vijayawada: Chief minister Chandrababu Naidu on Wednesday directed all ministers to attend the Assembly prepared with subject ...
But there's one problem with the SaaSpocalypse story: It might be totally false. Investor fears about software being replaced with AI might be overblown.
Speaking at the India Today Tamil Nadu Roundtable, BJP's K Annamalai and Congress MP Karti Chidambaram locked horns on the upcoming elections, as well as the Vijay factor.
NDA leaders to file ‘breach of privilege’ notice against Rahul for ‘unsubstantiated’ remarks on Puri
Kiren Rijiju accuses Rahul Gandhi of lying in his Lok Sabha speech and plans to seek expungement from House records.
Skills in the nuclear sector have been high on the agenda across Westminster in recent weeks, with several successful events highlighting how ...
US FDA accepts and grants priority review status to Takeda’s oveporexton for the treatment of narcolepsy type 1: Osaka, Japan Wednesday, February 11, 2026, 12:00 Hrs [IST] Taked ...
Angry villagers are not ready to concede defeat despite being told an historic footbridge is to be demolished. The steel walkway was built in compensation for the loss of land, roads and paths when ...
Consistent performance across NDA 155 and 156 reinforces the standing of Doon Defence Dreamers in India’s defence education ecosystem. Doon Defence Dreamers has reinforced its reputation in India’s de ...
Union minister Kiren Rijiju on Tuesday said "very ugly scenes" could have taken place had the BJP MPs been allowed to confront the Congress members on the day Prime Minister Narendra Modi was supposed ...
The FDA is expected to decide on treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results